뒤로
Cynata Therapeutics Limited(CYYNF) 가격
CYYNF 주가 차트
CYYNF 수입
Cynata Therapeutics Limited
$0.15
0%
$0
종가: Jan 26, 16:00:00 GMT-5
$0.15
0%
$0
애프터마켓: Jan 26, 17:47:10 GMT-5
주요 통계
이전 종가
$0.15
시가
$0.15
일일 범위
$0.11 - $0.15
52주 범위
$0.08 - $0.15
거래량
220
평균 거래량
32
EPS(TTM)
-0.03
배당수익률
--
시가총액
$35.6M
CYNATA THERAPEUTICS LTD란 무엇인가요?
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The firm is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells (iPSCs) to manufacture cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale. Its product candidates include CYP-001, CYP-004 and CYP-006TK. CYP-001 is under Phase II clinical trials with a focus on treatment for steroid-resistant acute graft versus host disease (GvHD) and a Phase 1/II trial in patients undergoing kidney transplantation. CYP-006TK is a Cymerus iPSC-derived MSC topical wound dressing product candidate. This product is used in the Company’s Phase I clinical trial in diabetic foot ulcers (DFU). CYP-004, is an iPSC-derived MSC product for intra-articular injection (injection into a joint), is ongoing with a Phase III trial in patients with osteoarthritis of the knee.